July 2024 | AIChE

You are here

July 2024

FDA clears GT BioPharma's IND for leukemia candidate

The FDA has cleared GT BioPharma's investigational new drug application to test its natural killer cell engager GTB-3650 as a - More -

J&J touts positive data for myasthenia gravis treatment

Johnson & Johnson has unveiled positive phase 3 results for nipocalimab, its anti-FcRn antibody developed to treat patients w - More -

SAF gains traction as renewable diesel profits wane

The declining profitability of renewable diesel production is pushing US refiners such as Valero Energy, Phillips 66 and Calu - More -

Texas oil and gas industry largely unscathed by Beryl

Hurricane Beryl's landfall in Texas on Monday left nearly 2.8 million people without power and affected operations at some pe - More -

Sensor detects miniscule quantities of the deadly opioid fentanyl

The synthetic opioid fentanyl, 50 times stronger than heroin, is a major driver of the US opioid overdose epidemic. - More -

Egyptian refinery upgrade completed

Middle East Oil Refinery, a subsidiary of Egyptian General Petroleum, has finished a refinery expansion project near Alexandr - More -

CureVac, GSK restructure mRNA agreement

GSK and CureVac announced their existing partnership involving the development of mRNA vaccines for infectious diseases has b - More -

Pages